5am Venture Management
$288M 13F equity value
20 Holdings
Quarter ended June 30, 2026
The latest 13F on file for 5am Venture Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MPLT | MAPLIGHT THERAPEUTICS INC | 950,011 | $34M | 11.8% |
| TYRA | TYRA BIOSCIENCES INC | 1,029,298 | $33M | 11.4% |
| TRDA | ENTRADA THERAPEUTICS INC | 4,056,379 | $30M | 10.4% |
| PHVS | PHARVARIS N V | 797,600 | $28M | 9.6% |
| CAMP | CAMP4 THERAPEUTICS CORP | 5,869,091 | $26M | 8.9% |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $23M | 7.9% |
| TECX | TECTONIC THERAPEUTIC INC | 606,660 | $21M | 7.2% |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3,947,913 | $19M | 6.7% |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 497,270 | $19M | 6.4% |
| EYPT | EYEPOINT INC | 1,050,000 | $15M | 5.2% |
Track 5am Venture Management's 13F portfolio: $288M in reported holdings, 20 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}